MedKoo Cat#: 465843 | Name: Physodic acid

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Physodic acid is a natural inhibitor of Wnt signaling, modulating β-catenin-dependent transcription.

Chemical Structure

Physodic acid
Physodic acid
CAS#84-24-2

Theoretical Analysis

MedKoo Cat#: 465843

Name: Physodic acid

CAS#: 84-24-2

Chemical Formula: C26H30O8

Exact Mass: 470.1941

Molecular Weight: 470.52

Elemental Analysis: C, 66.37; H, 6.43; O, 27.20

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Physodic acid; Physodalin; NSC-685589; NSC685589; NSC 685589;
IUPAC/Chemical Name
3,8-dihydroxy-11-oxo-1-(2-oxoheptyl)-6-pentyl-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid
InChi Key
KVTYWHGIZSCFLG-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H30O8/c1-3-5-7-9-16(27)11-15-12-17(28)13-20-22(15)26(32)34-21-14-19(29)23(25(30)31)18(24(21)33-20)10-8-6-4-2/h12-14,28-29H,3-11H2,1-2H3,(H,30,31)
SMILES Code
CCCCCC1=C(C(O)=O)C(O)=CC(O2)=C1OC3=CC(O)=CC(CC(CCCCC)=O)=C3C2=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 470.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kello M, Kuruc T, Petrova K, Goga M, Michalova Z, Coma M, Rucova D, Mojzis J. Pro-Apoptotic Potential of Pseudevernia furfuracea (L.) Zopf Extract and Isolated Physodic Acid in Acute Lymphoblastic Leukemia Model In Vitro. Pharmaceutics. 2021 Dec 16;13(12):2173. doi: 10.3390/pharmaceutics13122173. PMID: 34959454; PMCID: PMC8703293. 2: Mohammadi M, Bagheri L, Badreldin A, Fatehi P, Pakzad L, Suntres Z, van Wijnen AJ. Biological Effects of Gyrophoric Acid and Other Lichen Derived Metabolites, on Cell Proliferation, Apoptosis and Cell Signaling pathways. Chem Biol Interact. 2022 Jan 5;351:109768. doi: 10.1016/j.cbi.2021.109768. Epub 2021 Dec 3. PMID: 34864007; PMCID: PMC8808380. 3: Singh G, Armaleo D, Dal Grande F, Schmitt I. Depside and Depsidone Synthesis in Lichenized Fungi Comes into Focus through a Genome-Wide Comparison of the Olivetoric Acid and Physodic Acid Chemotypes of Pseudevernia furfuracea. Biomolecules. 2021 Oct 2;11(10):1445. doi: 10.3390/biom11101445. PMID: 34680078; PMCID: PMC8533459. 4: Papierska K, Krajka-Kuźniak V, Paluszczak J, Kleszcz R, Skalski M, Studzińska-Sroka E, Baer-Dubowska W. Lichen-Derived Depsides and Depsidones Modulate the Nrf2, NF-κB and STAT3 Signaling Pathways in Colorectal Cancer Cells. Molecules. 2021 Aug 7;26(16):4787. doi: 10.3390/molecules26164787. PMID: 34443375; PMCID: PMC8400444. 5: Ureña-Vacas I, González-Burgos E, Divakar PK, Gómez-Serranillos MP. Lichen Depsidones with Biological Interest. Planta Med. 2021 May 25. doi: 10.1055/a-1482-6381. Epub ahead of print. PMID: 34034351. 6: Studzińska-Sroka E, Majchrzak-Celińska A, Zalewski P, Szwajgier D, Baranowska-Wójcik E, Żarowski M, Plech T, Cielecka-Piontek J. Permeability of Hypogymnia physodes Extract Component-Physodic Acid through the Blood- Brain Barrier as an Important Argument for Its Anticancer and Neuroprotective Activity within the Central Nervous System. Cancers (Basel). 2021 Apr 5;13(7):1717. doi: 10.3390/cancers13071717. PMID: 33916370; PMCID: PMC8038629. 7: Petrova K, Kello M, Kuruc T, Backorova M, Petrovova E, Vilkova M, Goga M, Rucova D, Backor M, Mojzis J. Potential Effect of Pseudevernia furfuracea (L.) Zopf Extract and Metabolite Physodic Acid on Tumour Microenvironment Modulation in MCF-10A Cells. Biomolecules. 2021 Mar 12;11(3):420. doi: 10.3390/biom11030420. PMID: 33809098; PMCID: PMC8000760. 8: Komaty S, Sauvager A, Bazureau JP, Tomasi S, Paquin L. Efficiency and selectivity of ionic liquids in microwave-assisted extraction of major lichen phenolic compounds: a scalable process with recycling of ionic liquids. Phytochem Anal. 2021 Jul;32(4):592-600. doi: 10.1002/pca.3008. Epub 2020 Nov 4. PMID: 33150689. 9: Ingelfinger R, Henke M, Roser L, Ulshöfer T, Calchera A, Singh G, Parnham MJ, Geisslinger G, Fürst R, Schmitt I, Schiffmann S. Unraveling the Pharmacological Potential of Lichen Extracts in the Context of Cancer and Inflammation With a Broad Screening Approach. Front Pharmacol. 2020 Sep 4;11:1322. doi: 10.3389/fphar.2020.01322. PMID: 33013369; PMCID: PMC7509413. 10: Gandhi AD, Sathiyaraj S, Suriyakala G, Saranya S, Baskaran TN, Ravindran B, Babujanarthanam R. Lichens in Genus Parmelia: An Overview and their Application. Curr Pharm Biotechnol. 2020;21(13):1289-1297. doi: 10.2174/1389201021666200406105212. PMID: 32250223. 11: Staples R, LaDuca RL, Roze LV, Laivenieks M, Linz JE, Beaudry R, Fryday A, Schilmiller AL, Koptina AV, Smith B, Trail F. Structure and Chemical Analysis of Major Specialized Metabolites Produced by the Lichen Evernia prunastri. Chem Biodivers. 2020 Jan;17(1):e1900465. doi: 10.1002/cbdv.201900465. Epub 2020 Jan 10. PMID: 31701649. 12: Ručová D, Goga M, Sabovljević M, Vilková M, Petruľová V, Bačkor M. Insights into physiological responses of mosses Physcomitrella patens and Pohlia drummondii to lichen secondary metabolites. Protoplasma. 2019 Nov;256(6):1585-1595. doi: 10.1007/s00709-019-01403-0. Epub 2019 Jun 26. PMID: 31243559. 13: Sieteiglesias V, González-Burgos E, Bermejo-Bescós P, Divakar PK, Gómez- Serranillos MP. Lichens of Parmelioid Clade as Promising Multitarget Neuroprotective Agents. Chem Res Toxicol. 2019 Jun 17;32(6):1165-1177. doi: 10.1021/acs.chemrestox.9b00010. Epub 2019 Jun 7. PMID: 31125207. 14: Emsen B, Togar B, Turkez H, Aslan A. Effects of two lichen acids isolated from Pseudevernia furfuracea (L.) Zopf in cultured human lymphocytes. Z Naturforsch C J Biosci. 2018 Jul 26;73(7-8):303-312. doi: 10.1515/znc-2017-0209. PMID: 29573381. 15: Stojanović G, Zlatanović I, Zrnzević I, Stanković M, Stankov Jovanović V, Zlatković B. Hypogymnia tubulosa extracts: chemical profile and biological activities. Nat Prod Res. 2018 Nov;32(22):2735-2739. doi: 10.1080/14786419.2017.1375926. Epub 2017 Sep 13. PMID: 28901170. 16: Paluszczak J, Kleszcz R, Studzińska-Sroka E, Krajka-Kuźniak V. Lichen- derived caperatic acid and physodic acid inhibit Wnt signaling in colorectal cancer cells. Mol Cell Biochem. 2018 Apr;441(1-2):109-124. doi: 10.1007/s11010-017-3178-7. Epub 2017 Sep 8. PMID: 28887754; PMCID: PMC5843697. 17: Cardile V, Graziano ACE, Avola R, Piovano M, Russo A. Potential anticancer activity of lichen secondary metabolite physodic acid. Chem Biol Interact. 2017 Feb 1;263:36-45. doi: 10.1016/j.cbi.2016.12.007. Epub 2016 Dec 21. PMID: 28012710. 18: Reddy RG, Veeraval L, Maitra S, Chollet-Krugler M, Tomasi S, Dévéhat FL, Boustie J, Chakravarty S. Lichen-derived compounds show potential for central nervous system therapeutics. Phytomedicine. 2016 Nov 15;23(12):1527-1534. doi: 10.1016/j.phymed.2016.08.010. Epub 2016 Aug 31. PMID: 27765373. 19: Talapatra SK, Rath O, Clayton E, Tomasi S, Kozielski F. Depsidones from Lichens as Natural Product Inhibitors of M-Phase Phosphoprotein 1, a Human Kinesin Required for Cytokinesis. J Nat Prod. 2016 Jun 24;79(6):1576-85. doi: 10.1021/acs.jnatprod.5b00962. Epub 2016 Jun 14. PMID: 27300079. 20: Emsen B, Turkez H, Togar B, Aslan A. Evaluation of antioxidant and cytotoxic effects of olivetoric and physodic acid in cultured human amnion fibroblasts. Hum Exp Toxicol. 2017 Apr;36(4):376-385. doi: 10.1177/0960327116650012. Epub 2016 May 20. PMID: 27206701.